News

Investors choose to redeem or convert the majority of Series C and Series D Preferred 99% of outstanding preferred series C shares are redeemed or converted and preferred series D reduced 68.5% in out ...
Liminatus Pharma and CEA Industries announce $1B combined BNB treasury allocations, driving exchange token market to $161B cap.
BNB rose over 6.6% in the last 24-hour window as a wave of corporate treasury purchases and a recently announced trade deal ...
BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.
BNB price grazed the $800 mark on Sunday, printing 7% gains in three consecutive days of trading. The Binance Coin rally coincides with Nasdaq-listed Windtree Therapeutics committing $520 million for ...
Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...
After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, ...
Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...
Windtree Therapeutics secures $520M to pivot into a BNB-focused crypto treasury strategy, marking a bold move for corporate ...
Publicly traded companies are increasingly integrating cryptocurrencies other than Bitcoin (CRYPTO: BTC), into their treasuries, with significant investments announced in Ethereum (CRYPTO: ETH), Solan ...
Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...
Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...